MYC and acute lymphoblastic leukemia: In the presence of substrate coelenterazine, PGK-RLuc enables tracking of all T-ALL cells noninvasively in vivo, immediately after subcutaneous cell implantation, and before and after doxycycline-mediated MYC inactivation.